Clinical Trial Update: Delayed Versus Early Enoxaparin Prophylaxis After Traumatic Brain Injury (TBI) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial comparing delayed versus early enoxaparin prophylaxis after traumatic brain injury completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury
• Venous Thromboembolism

Drugs mentioned

• Enoxaparin (enoxaparin sodium)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Venous Thromboembolism, Traumatic Brain Injury | Phase 1 | Status: COMPLETED | Results posted: 2021-01-13